These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2216207

  • 1. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Haeger M, Unander M, Bengtsson A.
    Obstet Gynecol; 1990 Oct; 76(4):698-702. PubMed ID: 2216207
    [Abstract] [Full Text] [Related]

  • 2. Complement activation in relation to development of preeclampsia.
    Haeger M, Unander M, Bengtsson A.
    Obstet Gynecol; 1991 Jul; 78(1):46-9. PubMed ID: 2047067
    [Abstract] [Full Text] [Related]

  • 3. Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A.
    Obstet Gynecol; 1992 Jan; 79(1):19-26. PubMed ID: 1727579
    [Abstract] [Full Text] [Related]

  • 4. Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Ari E, Yilmaz Y, Gul A, Alahdab YO, Kedrah AE, Macunluoglu B, Aydin A, Arikan H, Ozener C.
    Am J Reprod Immunol; 2009 Oct; 62(4):238-42. PubMed ID: 19703145
    [Abstract] [Full Text] [Related]

  • 5. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia.
    Weinstein L.
    Obstet Gynecol; 1985 Nov; 66(5):657-60. PubMed ID: 4058824
    [Abstract] [Full Text] [Related]

  • 6. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M, Bengtson A, Karlsson K, Heideman M.
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [Abstract] [Full Text] [Related]

  • 7. Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.
    Burwick RM, Feinberg BB.
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1059-S1070. PubMed ID: 32986992
    [Abstract] [Full Text] [Related]

  • 8. Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Haeger M, Unander M, Andersson B, Tarkowski A, Arnestad JP, Bengtsson A.
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):695-701. PubMed ID: 8906000
    [Abstract] [Full Text] [Related]

  • 9. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.
    Rønholm E, Tomasdottir H, Runeborg J, Bengtsson A, Bengtson JP, Stenqvist O, Friman S.
    Transplantation; 1994 Jun 15; 57(11):1594-7. PubMed ID: 8009593
    [Abstract] [Full Text] [Related]

  • 10. Hemolysis, elevated liver enzymes and low platelet count. The HELLP syndrome.
    Bertakis KD, Hufford DB.
    West J Med; 1986 Jan 15; 144(1):81-3. PubMed ID: 3953075
    [No Abstract] [Full Text] [Related]

  • 11. Relative inefficiency of terminal complement activation.
    Bhakdi S, Fassbender W, Hugo F, Carreno MP, Berstecher C, Malasit P, Kazatchkine MD.
    J Immunol; 1988 Nov 01; 141(9):3117-22. PubMed ID: 3262681
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D.
    Acta Med Croatica; 2004 Nov 01; 58(1):31-6. PubMed ID: 15125391
    [Abstract] [Full Text] [Related]

  • 13. [Disorders of liver function, thrombopenia and hemolysis in a special clinical form of hypertension in pregnancy (the so-called HELLP syndrome)].
    Niesert S, Dribusch E, Bellmann O, Kaulhausen H.
    Geburtshilfe Frauenheilkd; 1988 Sep 01; 48(9):637-40. PubMed ID: 3181712
    [Abstract] [Full Text] [Related]

  • 14. The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome.
    Ozer A, Kanat-Pektas M, Ozer S, Tapisiz OL, Zulfikaroglu EE, Danisman N.
    Arch Gynecol Obstet; 2009 Jul 01; 280(1):65-70. PubMed ID: 19089438
    [Abstract] [Full Text] [Related]

  • 15. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome?
    Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N.
    Acta Obstet Gynecol Scand; 2007 Jul 01; 86(6):648-51. PubMed ID: 17520393
    [Abstract] [Full Text] [Related]

  • 16. [Follow-up in HELLP syndrome].
    Rosen A, Klein M, Beck A.
    Zentralbl Gynakol; 1990 Jul 01; 112(5):273-7. PubMed ID: 2353550
    [Abstract] [Full Text] [Related]

  • 17. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
    Schaefer RM, Rauterberg EW, Deppisch R, Vienken J.
    Miner Electrolyte Metab; 1990 Jul 01; 16(1):73-6. PubMed ID: 2325595
    [Abstract] [Full Text] [Related]

  • 18. [HELLP syndrome: a rare, threatening complication in pre-eclampsia].
    Dadak C, Feiks A, Lasnik E.
    Geburtshilfe Frauenheilkd; 1986 Sep 01; 46(9):637-9. PubMed ID: 3770412
    [Abstract] [Full Text] [Related]

  • 19. [HELLP syndrome in the 23d week of pregnancy. A case report and literature discussion].
    Grillo M, Bönig G, Weisner D.
    Zentralbl Gynakol; 1990 Sep 01; 112(1):39-43. PubMed ID: 2316293
    [Abstract] [Full Text] [Related]

  • 20. Antepartum reversal of hematologic abnormalities associated with the HELLP syndrome. A report of three cases.
    Clark SL, Phelan JR, Allen SH, Golde SR.
    J Reprod Med; 1986 Jan 01; 31(1):70-2. PubMed ID: 3950889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.